• 1
    Bikle DD, Halloran BP 1999 The response of bone to unloading. J Bone Miner Metab 17:233244.
  • 2
    Globus RK, Bikle DD, Morey-Holton E 1986 The temporal response of bone to unloading. Endocrinology 118:733742.
  • 3
    Halloran BP, Bikle DD, Harris J, Foskett HC, Morey-Holton E 1993 Skeletal unloading decreases production of 1,25-dihydroxyvitamin D. Am J Physiol 264:E712E716.
  • 4
    Halloran BP, Bikle DD, Harris J, Tanner S, Curren T, Morey-Holton E 1997 Regional responsiveness of the tibia to intermittent administration of parathyroid hormone as affected by skeletal unloading. J Bone Miner Res 12:10681074.
  • 5
    Matsumoto T, Nakayama K, Kodama Y, Fuse H, Nakamura T, Fukumoto S 1998 Effect of mechanical unloading and reloading on periosteal bone formation and gene expression in tail-suspended rapidly growing rats. Bone 22:89S93S.
  • 6
    Dehority W, Halloran BP, Bikle DD, Curren T, Kostenuik PJ, Wronski TJ, Shen Y, Rabkin B, Bouraoui A, Morey-Holton E 1999 Bone and hormonal changes induced by skeletal unloading in the mature male rat. Am J Physiol 276:E62E69.
  • 7
    Friedenstein AJ, Chailakhyan RK, Gerasimov UV 1987 Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20:263272.
  • 8
    Owen ME, Cave J, Joyner CJ 1987 Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F. J Cell Sci 87:731738.
  • 9
    Prockop DJ 1997 Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:7174.
  • 10
    Machwate M, Zerath E, Holy X, Hott M, Modrowski D, Malouvier A, Marie PJ 1993 Skeletal unloading in rat decreases proliferation of rat bone and marrow-derived osteoblastic cells. Am J Physiol 264:E790E799.
  • 11
    Zhang R, Supowit SC, Klein GL, Lu Z, Christensen MD, Lozano R, Simmons DJ 1995 Rat tail suspension reduces messenger RNA level for growth factors and osteopontin and decreases the osteoblastic differentiation of bone marrow stromal cells. J Bone Miner Res 10:415423.
  • 12
    Kostenuik PJ, Halloran BP, Morey-Holton ER, Bikle DD 1997 Skeletal unloading inhibits the in vitro proliferation and differentiation of rat osteoprogenitor cells. Am J Physiol 273:E1133E1139.
  • 13
    Van Wyk JJ, Smith EP 1999 Insulin-like growth factors and skeletal growth: Possibilities for therapeutic interventions. J Clin Endocrinol Metab 84:43494354.
  • 14
    LeRoith D 2000 Insulin-like growth factor I receptor signaling-overlapping or redundant pathways? Endocrinology 141:12871288.
  • 15
    Canalis E 1980 Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria. J Clin Invest 66:709719.
  • 16
    Hock JM, Centrella M, Canalis E 1988 Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254260.
  • 17
    Canalis E, McCarthy T, Centrella M 1988 Isolation and characterization of insulin-like growth factor I (somatomedin-C) from cultures of fetal rat calvariae. Endocrinology 122:2227.
  • 18
    Wergedal JE, Mohan S, Lundy M, Baylink DJ 1990 Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. J Bone Miner Res 5:179186.
  • 19
    LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143163.
  • 20
    LeRoith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:5374.
  • 21
    Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH 2001 Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 22:153183.
  • 22
    Borgatti P, Martelli AM, Bellacosa A, Casto R, Massari L, Capitani S, Neri LM 2000 Translocation of Akt/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors. FEBS Lett 477:2732.
  • 23
    Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME 1997 Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661665.
  • 24
    Franke TF, Kaplan DR, Cantley LC 1997 PI3K: Downstream AKTion blocks apoptosis. Cell 88:435437.
  • 25
    Chernoff J 1999 Protein tyrosine phosphatases as negative regulators of mitogenic signaling. J Cell Physiol 180:173181.
  • 26
    Maile LA, Clemmons DR 2002 Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2. J Biol Chem 277:89558960.
  • 27
    Buckley DA, Cheng A, Kiely PA, Tremblay ML, O'Connor R 2002 Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts. Mol Cell Biol 22:19982010.
  • 28
    Freeman RM Jr, Plutzky J, Neel BG 1992 Identification of a human src homology 2-containing protein-tyrosine-phosphatase: A putative homolog of Drosophila corkscrew. Proc Natl Acad Sci USA 89:1123911243.
  • 29
    Ahmad S, Banville D, Zhao Z, Fischer EH, Shen SH 1993 A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains. Proc Natl Acad Sci USA 90:219721201.
  • 30
    Giancotti FG, Ruoslahti E 1999 Integrin signaling. Science 285:10281032.
  • 31
    Zheng B, Clemmons DR 1998 Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc Natl Acad Sci USA 95:1121711222.
  • 32
    Clemmons DR, Horvitz G, Engleman W, Nichols T, Moralez A, Nickols GA 1999 Synthetic alphaVbeta3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication. Endocrinology 140:46164621.
  • 33
    Maile LA, Clemmons DR 2002 The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor. Endocrinology 143:42594264.
  • 34
    Bikle DD, Harris J, Halloran BP, Morey-Holton ER 1994 Skeletal unloading induces resistance to insulin-like growth factor I. J Bone Miner Res 9:17891796.
  • 35
    Kostenuik PJ, Harris J, Halloran BP, Turner RT, Morey-Holton ER, Bikle DD 1999 Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I. J Bone Miner Res 14:2131.
  • 36
    Sakata T, Halloran BP, ElAlieh HZ, Munson SJ, Rudner L, Venton L, Ginzinger D, Rosen CJ, Bikle DD 2003 Skeletal unloading induces resistance to insulin-like growth factor-I on bone formation. Bone 32:669680.
  • 37
    Swarup G, Speeg KV Jr, Cohen S, Garbers DL 1982 Phosphotyrosyl-protein phosphatase of TCRC-2 cells. J Biol Chem 257:72987301.
  • 38
    Kawase T, Orikasa M, Ogata S, Burns DM 1995 Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line. Arch Oral Biol 40:921929.
  • 39
    Jones JI, Prevette T, Gockerman A, Clemmons DR 1996 Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci USA 93:24822487.
  • 40
    Taylor SJ, Shalloway D 1996 Cell cycle-dependent activation of Ras. Curr Biol 6:16211627.
  • 41
    Foschi M, Chari S, Dunn MJ, Sorokin A 1997 Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase. EMBO J 16:64396451.
  • 42
    Lekanne Deprez RH, Fijnvandraat AC, Ruijter JM, Moorman AF 2002 Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions. Anal Biochem 307:6369.
  • 43
    Alfonso J, Pollevick GD, Castensson A, Jazin E, Frasch AC 2002 Analysis of gene expression in the rat hippocampus using Real Time PCR reveals high inter-individual variation in mRNA expression levels. J Neurosci Res 67:225234.
  • 44
    Ginzinger DG 2002 Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream. Exp Hematol 30:503512.
  • 45
    Barou O, Palle S, Vico L, Alexandre C, Lafage-Proust MH 1998 Hindlimb unloading in rat decreases preosteoblast proliferation assessed in vivo with BrdU incorporation. Am J Physiol 274:E108E114.
  • 46
    Joneson T, Bar-Sagi D 1997 Ras effectors and their role in mitogenesis and oncogenesis. J Mol Med 75:587593.
  • 47
    Martin JL, Baxter RC 1999 Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells. J Biol Chem 274:1640716411.
  • 48
    Miao D, Tong XK, Chan GK, Panda D, McPherson PS, Goltzman D 2001 Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem 276:3220432213.
  • 49
    Meadows KN, Bryant P, Pumiglia K 2001 Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem 276:4928949298.
  • 50
    Herrmann C, Nassar N 1996 Ras and its effectors. Prog Biophys Mol Biol 66:141.
  • 51
    Hughes DE, Salter DM, Dedhar S, Simpson R 1993 Integrin expression in human bone. J Bone Miner Res 8:527533.
  • 52
    Gronthos S, Stewart K, Graves SE, Hay S, Simmons PJ 1997 Integrin expression and function on human osteoblast-like cells. J Bone Miner Res 12:11891197.